Schedule 13G ownership disclosure
PROTEOSTASIS THERAPEUTICS, INC.
Security class unavailable · CUSIP: 74373B109
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,356,541
- Percent of class
- 2.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-005828
- Form type
- SC 13G
- Filer
- Novartis Bioventures Ltd
- CIK
- CIK 1297709
- Filed
- Feb 05, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership